Evolent Health Inc (EVH)
27.49
+0.25
(+0.92%)
USD |
NYSE |
May 07, 14:15
Evolent Health Cash from Investing (TTM): -415.54M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -415.54M |
September 30, 2023 | -413.95M |
June 30, 2023 | -662.79M |
March 31, 2023 | -670.87M |
December 31, 2022 | -259.12M |
September 30, 2022 | -309.03M |
June 30, 2022 | -55.84M |
March 31, 2022 | -44.97M |
December 31, 2021 | -15.79M |
September 30, 2021 | 36.36M |
June 30, 2021 | 319.83M |
March 31, 2021 | 317.83M |
December 31, 2020 | 261.07M |
September 30, 2020 | 184.12M |
June 30, 2020 | -109.20M |
March 31, 2020 | -166.96M |
December 31, 2019 | -181.63M |
September 30, 2019 | -237.90M |
June 30, 2019 | -231.82M |
Date | Value |
---|---|
March 31, 2019 | -173.17M |
December 31, 2018 | -160.38M |
September 30, 2018 | -53.16M |
June 30, 2018 | -32.98M |
March 31, 2018 | -29.57M |
December 31, 2017 | -12.26M |
September 30, 2017 | -57.87M |
June 30, 2017 | -76.85M |
March 31, 2017 | -78.38M |
December 31, 2016 | -96.66M |
September 30, 2016 | -77.64M |
June 30, 2016 | -78.20M |
March 31, 2016 | -57.34M |
December 31, 2015 | -43.68M |
September 30, 2015 | 11.14M |
June 30, 2015 | 16.05M |
March 31, 2015 | 39.68M |
December 31, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-670.87M
Minimum
Mar 2023
319.83M
Maximum
Jun 2021
-139.80M
Average
-166.96M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
American Shared Hospital Services | -6.273M |
Novo Integrated Sciences Inc | -- |
Astrana Health Inc | -65.52M |
Cryo-Cell International Inc | -7.284M |
P3 Health Partners Inc | -1.827M |